Drug Shortage Report for TEVA-CANDESARTAN/HCTZ

Last updated on 2020-04-23 History
Report ID 99932
Drug Identification Number 02395568
Brand name TEVA-CANDESARTAN/HCTZ
Common or Proper name CANDESARTAN/HCTZ 32/12.5MG TB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 PP
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-04-30
Actual end date 2020-04-22
Shortage status Resolved
Updated date 2020-04-23
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-04-23 French Compare
v12 2020-04-23 English Compare
v11 2020-03-26 French Compare
v10 2020-03-26 English Compare
v9 2020-03-05 French Compare
v8 2020-03-05 English Compare
v7 2020-01-24 French Compare
v6 2020-01-24 English Compare
v5 2019-12-05 French Compare
v4 2019-12-05 English Compare
v3 2019-11-29 English Compare
v2 2019-11-28 French Compare
v1 2019-11-28 English Compare